• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以乙基纤维素10级和卡波姆934P NF作为控释聚合物的氯沙坦钾控释基质的制备及体外评价

Preparation and In Vitro Evaluation of Controlled-Release Matrices of Losartan Potassium Using Ethocel Grade 10 and Carbopol 934P NF as Rate-Controlling Polymers.

作者信息

Khan Kamran Ahmad, Zizzadoro Claudia, Di Cerbo Alessandro, Pugliese Nicola, Khan Gul Majid, Ghazanfar Shakira, Almusalami Eman M, Muzammal Muhammad, Alsalman Khaled J, Farid Arshad

机构信息

Gomal Center of Pharmaceutical Sciences, Faculty of Pharmacy, Gomal University, Dera Ismail Khan 29050, Pakistan.

Department of Veterinary Medicine, University of Bari, 70010 Valenzano, Italy.

出版信息

Polymers (Basel). 2022 Jul 24;14(15):2993. doi: 10.3390/polym14152993.

DOI:10.3390/polym14152993
PMID:35893957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9331966/
Abstract

Controlled-release formulations are essential for those drugs that require fine tuning of their activity to increase the ratio between therapeutic vs. adverse effects. Losartan potassium is among those drugs whose adverse effects may somehow impair its purported benefits. Previous investigations have been carried out to ascertain the suitability of several polymers for being associated with losartan. This study is focused on the effects of Ethocel grade 10 and Carbopol 934P NF on losartan release. Flow and physical properties were assessed according to the protocols standardized by the pharmacopeia (USP-NF 29), and the drug release in phosphate buffer (pH = 6.8) was measured for 24 h. Data evidenced good to excellent flow and physical properties according to the drug/polymer ratio and the addition of co-excipients. The release rate in 24 h was found to be 63-69% to 79-82% without or with the addition of co-excipients, respectively, following zero-order kinetics. The results also suggest a significant difference with the release profile of a traditional release losartan formulation. The results suggest the suitability of Ethocel grade 10 and Carbopol 934P NF as components of a controlled-release losartan formulation.

摘要

控释制剂对于那些需要精确调节活性以提高治疗效果与不良反应之比的药物至关重要。氯沙坦钾属于那些其不良反应可能会在某种程度上削弱其宣称益处的药物。此前已经开展了多项研究,以确定几种聚合物与氯沙坦联用的适用性。本研究聚焦于乙基纤维素10级和卡波姆934P NF对氯沙坦释放的影响。根据药典(USP-NF 29)标准化的方案评估流动性和物理性质,并在磷酸盐缓冲液(pH = 6.8)中测量药物释放24小时。数据表明,根据药物/聚合物比例和共辅料的添加情况,流动性和物理性质良好至优异。在不添加或添加共辅料的情况下,24小时内的释放率分别为63 - 69%至79 - 82%,遵循零级动力学。结果还表明,与传统释放的氯沙坦制剂的释放曲线存在显著差异。结果表明乙基纤维素10级和卡波姆934P NF适合作为氯沙坦控释制剂的成分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df27/9331966/58f87903f485/polymers-14-02993-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df27/9331966/182f250ad640/polymers-14-02993-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df27/9331966/58f87903f485/polymers-14-02993-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df27/9331966/182f250ad640/polymers-14-02993-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df27/9331966/58f87903f485/polymers-14-02993-g002.jpg

相似文献

1
Preparation and In Vitro Evaluation of Controlled-Release Matrices of Losartan Potassium Using Ethocel Grade 10 and Carbopol 934P NF as Rate-Controlling Polymers.以乙基纤维素10级和卡波姆934P NF作为控释聚合物的氯沙坦钾控释基质的制备及体外评价
Polymers (Basel). 2022 Jul 24;14(15):2993. doi: 10.3390/polym14152993.
2
Formulation and in-vitro evaluation of directly compressed controlled release matrices of Losartan Potassium using Ethocel Grade 100 as rate retarding agent.采用羟丙甲纤维素 100 作为控释速率的延迟剂,对氯沙坦钾进行直接压片控释制剂的配方和体外评价。
Int J Pharm. 2015 Dec 30;496(2):759-65. doi: 10.1016/j.ijpharm.2015.10.051. Epub 2015 Nov 3.
3
Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents.采用控释制剂辅料制备氯沙坦钾及其体外考察。
Molecules. 2022 Jan 27;27(3):864. doi: 10.3390/molecules27030864.
4
Design, Preparation and evaluation of various parameters of controlled release matrices of losartan potassium using polymers combination.设计、制备和评价使用聚合物组合的氯沙坦钾控释基质的各种参数。
Pak J Pharm Sci. 2020 Sep;33(5(Supplementary)):2231-2237.
5
Formulation and Preparation of Losartan-Potassium-Loaded Controlled-Release Matrices Using Ethocel Grade 10 to Establish a Correlation between In Vitro and In Vivo Results.使用乙基纤维素10级制备载有氯沙坦钾的控释基质并建立体外与体内结果之间的相关性。
Pharmaceutics. 2024 Jan 28;16(2):186. doi: 10.3390/pharmaceutics16020186.
6
To study the influence of different grades of Ethylcellulose ether derivative polymer Ethocel® and co-excipient on drug release profile of controlled release matrix tablet of acarbose.研究不同等级的乙基纤维素醚衍生物聚合物Ethocel®及辅料对阿卡波糖控释骨架片药物释放曲线的影响。
Pak J Pharm Sci. 2015 Nov;28(6 Suppl):2259-65.
7
Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.含亲水性聚合物的布洛芬控释片的处方开发与研究以及辅料对药物释放模式的影响
Pak J Pharm Sci. 2012 Oct;25(4):751-6.
8
Formulation and in vitro evaluation of directly compressed controlled release tablets designed from the Co-precipitates.由共沉淀物设计的直接压片控释片的处方及体外评价
Pak J Pharm Sci. 2018 Mar;31(2):455-461.
9
Development and evaluation of chitosan based oral controlled matrix tablets of losartan potassium.氯沙坦钾壳聚糖基口服控释骨架片的研制与评价
Int J Pharm Investig. 2012 Jul;2(3):157-61. doi: 10.4103/2230-973X.104399.
10
Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.研究双氯芬酸钾-乙基纤维素控释骨架片的体外药物释放动力学以及辅料对药物释放模式的影响。
Pak J Pharm Sci. 2011 Apr;24(2):183-92.

引用本文的文献

1
Fabrication of glipizide loaded polymeric microparticles; in-vitro and in-vivo evaluation.格列吡嗪负载型聚合物微粒的制备;体外和体内评价
PLoS One. 2025 Jan 9;20(1):e0313523. doi: 10.1371/journal.pone.0313523. eCollection 2025.
2
Unveiling Swelling and Erosion Dynamics: Early Development Screening of Mirabegron Extended Release Tablets.揭示肿胀和侵蚀动态:米拉贝隆缓释片的早期开发筛选。
AAPS PharmSciTech. 2024 Nov 27;25(8):277. doi: 10.1208/s12249-024-02994-5.
3
Formulation and Preparation of Losartan-Potassium-Loaded Controlled-Release Matrices Using Ethocel Grade 10 to Establish a Correlation between In Vitro and In Vivo Results.

本文引用的文献

1
Nanocrytals-Mediated Oral Drug Delivery: Enhanced Bioavailability of Amiodarone.纳米晶体介导的口服药物递送:胺碘酮生物利用度的提高
Pharmaceutics. 2022 Jun 18;14(6):1300. doi: 10.3390/pharmaceutics14061300.
2
Formulation Development and Ex-Vivo Permeability of Curcumin Hydrogels under the Influence of Natural Chemical Enhancers.天然化学增强剂作用下姜黄素水凝胶的制剂开发与体外渗透性
Gels. 2022 Jun 16;8(6):384. doi: 10.3390/gels8060384.
3
Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin.
使用乙基纤维素10级制备载有氯沙坦钾的控释基质并建立体外与体内结果之间的相关性。
Pharmaceutics. 2024 Jan 28;16(2):186. doi: 10.3390/pharmaceutics16020186.
4
Preparation and In Vitro Evaluation of Levofloxacin-Loaded Floating Tables Using Various Rate-Controlling Agents.使用各种速率控制剂制备载有左氧氟沙星的漂浮片并进行体外评价。
ACS Omega. 2023 Nov 1;8(45):42659-42666. doi: 10.1021/acsomega.3c05419. eCollection 2023 Nov 14.
5
mucilage nanoparticles of losartan potassium: Characterization and pharmacodynamics evaluation.氯沙坦钾黏液纳米颗粒:表征与药效学评价
Saudi Pharm J. 2023 Aug;31(8):101695. doi: 10.1016/j.jsps.2023.101695. Epub 2023 Jul 6.
6
Synthesis of Starch-Grafted Polymethyl Methacrylate via Free Radical Polymerization Reaction and Its Application for the Uptake of Methylene Blue.通过自由基聚合反应合成淀粉接枝聚甲基丙烯酸甲酯及其对亚甲基蓝的吸附性能。
Molecules. 2022 Sep 9;27(18):5844. doi: 10.3390/molecules27185844.
埃索美拉唑和克拉霉素控释漂浮双层片的制备与表征。
Molecules. 2022 May 18;27(10):3242. doi: 10.3390/molecules27103242.
4
Formulation and Characterization of Chitosan-Decorated Multiple Nanoemulsion for Topical Delivery In Vitro and Ex Vivo.壳聚糖修饰的多重纳米乳液的配方与表征及其体外和体内经皮给药。
Molecules. 2022 May 17;27(10):3183. doi: 10.3390/molecules27103183.
5
Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery.载氯诺昔康的壳聚糖修饰纳米乳剂:用于增强透皮给药的制备及体外评价
Polymers (Basel). 2022 May 9;14(9):1922. doi: 10.3390/polym14091922.
6
Formulation and Evaluation of Hydrophilic Polymer Based Methotrexate Patches: In Vitro and In Vivo Characterization.基于亲水性聚合物的甲氨蝶呤贴片的制剂与评价:体外和体内特性研究
Polymers (Basel). 2022 Mar 24;14(7):1310. doi: 10.3390/polym14071310.
7
Tacrolimus-Loaded Solid Lipid Nanoparticle Gel: Formulation Development and In Vitro Assessment for Topical Applications.载有他克莫司的固体脂质纳米粒凝胶:用于局部应用的制剂开发与体外评估
Gels. 2022 Feb 18;8(2):129. doi: 10.3390/gels8020129.
8
Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents.采用控释制剂辅料制备氯沙坦钾及其体外考察。
Molecules. 2022 Jan 27;27(3):864. doi: 10.3390/molecules27030864.
9
Metronidazole Based Floating Bioadhesive Drug Delivery System for Potential Eradication of : Preparation and In Vitro Characterization.基于甲硝唑的漂浮型生物黏附药物递送系统用于潜在根除:制备与体外表征
Polymers (Basel). 2022 Jan 27;14(3):519. doi: 10.3390/polym14030519.
10
Advances in Oral Drug Delivery.口服给药递送的进展
Front Pharmacol. 2021 Feb 19;12:618411. doi: 10.3389/fphar.2021.618411. eCollection 2021.